Home Applications 209445 Application 209445
Type NDA
Sponsor SHIONOGI INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FETROJA CEFIDEROCOL SULFATE TOSYLATE POWDER;INTRAVENOUS EQ 1GM BASE/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209445-001 FETROJA CEFIDEROCOL SULFATE TOSYLATE EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 N209445-001 9949982 2035-09-03 Drug product 2019-12-11
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N209445-001 NCE 2024-11-14 N209445-001 GAIN 2029-11-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 3f01610625f2…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209445-001 FETROJA EQ 1GM BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2019-11-14 e64feba35796…
Observed Orange Book patent history# Patent history page 1 of 5 · 182 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 c2088c7a36db…2026-09-14 22:38:34 2026-08 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209445-001 9238657 2033-11-14 U-282 Drug substance, Drug product 2019-12-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209445-001 9238657 2033-11-14 U-3470 Drug substance, Drug product 2019-12-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209445-001 9238657 2033-11-14 U-3471 Drug substance, Drug product 2019-12-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209445-001 10004750 2035-09-03 Drug substance, Drug product 2019-12-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209445-001 9949982 2035-09-03 Drug product 2019-12-11 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 3 of 3 · 103 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 59630-266 Fetroja Cefiderocol sulfate tosylate Shionogi Inc. NDA Current 59630-266 Fetroja Cefiderocol sulfate tosylate Shionogi Inc. NDA Current 59630-266 Fetroja Cefiderocol sulfate tosylate Shionogi Inc. NDA Current 59630-266 Fetroja Cefiderocol sulfate tosylate Shionogi Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 82507 SUPPL 2025-06-09 82493 SUPPL 2025-06-09 69312 SUPPL 2021-11-15 69308 SUPPL 2021-11-15 64882 SUPPL 2020-10-08 64738 SUPPL 2020-09-29 64694 SUPPL 2020-09-28 61345 ORIG 2019-12-19 60850 ORIG 2019-11-15 60846 ORIG 2019-11-15